Determinants of functional mitral regurgitation severity in patients with ischemic cardiomyopathy versus nonischemic dilated cardiomyopathy

Determinants of functional mitral regurgitation severity in patients with ischemic cardiomyopathy versus nonischemic dilated cardiomyopathy

Show other versions (1)

Aims Functional mitral regurgitation (MR) is prevalent among patients with left ventricular (LV) dysfunction and is associated with a poorer prognosis. Our aim was to assess the primary determinants of MR severity in patients with ischemic cardiomyopathy (ICM) and nonischemic dilated cardiomyopathy...

Full description

Bibliographic Details
Main Authors:	Konstantinou, D, Papadopoulou, K, Giannakoulas, G, Kamperidis, V, Dalamanga, E, Damvopoulou, E, Parcharidou, D, Karamitsos, T, Karvounis, H
Format:	Journal article
Language:	English
Published:	2014

Similar Items

Determinants of functional mitral regurgitation severity in patients with ischemic cardiomyopathy versus nonischemic dilated cardiomyopathy.
by: Konstantinou, D, et al.
Published: (2014)

Differences in echocardiographic characteristics of functional mitral regurgitation in ischaemic versus idiopathic dilated cardiomyopathy: a pilot study.
by: Papadopoulou, K, et al.
Published: (2009)

Ischemic versus dilated cardiomyopathy. incremental diagnostic value of Tissue Doppler Imaging
by: Papadopoulou, K, et al.
Published: (2006)

Improved papillary muscle function attenuates functional mitral regurgitation in patients with dilated cardiomyopathy after cardiac resynchronization therapy.
by: Karvounis, H, et al.
Published: (2006)

The Prognostic Value of Late Gadolinium Enhancement CMR in Nonischemic Cardiomyopathies
by: Karamitsos, T, et al.
Published: (2013)

The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies.
by: Karamitsos, T, et al.
Published: (2013)

The current and emerging role of cardiovascular magnetic resonance in the diagnosis of nonischemic cardiomyopathies.
by: Karamitsos, T, et al.
Published: (2011)

Dilated cardiomyopathy and the desmin gene.
by: Mayosi, B, et al.
Published: (2000)

The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies topical collection on cardiac PET, CT, and MRI
by: Karamitsos, T, et al.
Published: (2013)

Metabolic imaging in dilated cardiomyopathy
by: Neubauer, S
Published: (2011)

Hyperubiquitination of proteins in dilated cardiomyopathy.
by: Weekes, J, et al.
Published: (2003)

Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy.
by: Tentolouris, C, et al.
Published: (2004)

Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.
by: Lakdawala, N, et al.
Published: (2010)

Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis
by: Suttie, J, et al.
Published: (2011)

Molecular and genetic dissection of dilated cardiomyopathy
by: Hafizah Khalidh
Published: (2015)

Reevaluating the genetic contribution of monogenic dilated cardiomyopathy
by: Mazzarotto, F, et al.
Published: (2020)

Recurrence of mitral valve regurgitation after mitral valve repair.
by: Myerson, S
Published: (2003)

Obesity modifies the energetic phenotype in dilated cardiomyopathy
by: Rayner, JJ, et al.
Published: (2021)

Prediction of clinical outcome in asymptomatic mitral regurgitation using CMR
by: D'arcy, J, et al.
Published: (2011)

Multiscale technologies for treatment of ischemic cardiomyopathy
by: Mahmoudi, Morteza, et al.
Published: (2022)

Multiscale technologies for treatment of ischemic cardiomyopathy
by: Mahmoudi, Morteza, et al.
Published: (2021)

Dilated Cardiomyopathy: Phosphorus 31 MR Spectroscopy at 7 T
by: Stoll, V, et al.
Published: (2016)

Quantification of regurgitant fraction in mitral regurgitation by cardiovascular magnetic resonance: comparison of techniques.
by: Kon, M, et al.
Published: (2004)

Clinical significance of N-terminal proBrain natriuretic peptide in hypertophic cardiomyopathy
by: Efthimiadis, G, et al.
Published: (2006)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
by: Watkins, H
Published: (2003)

Determination of clinical outcome in mitral regurgitation with cardiovascular magnetic resonance quantitation
by: Myerson, S, et al.
Published: (2016)

Artificial muscle technology applied towards treating ischemic mitral regurgitation caused by left ventricular remodeling
by: Sabourin, Nicaulas A. (Nicaulas Alexandre), 1978-
Published: (2005)

Investigation of a transgenic mouse model of familial dilated cardiomyopathy.
by: Song, W, et al.
Published: (2010)

Clinical significance of N-terminal-probrain natriuretic peptide in hypertrophic cardiomyopathy.
by: Efthimiadis, G, et al.
Published: (2007)

Regression of dilated-hypokinetic hypertrophic cardiomyopathy by biventricular cardiac pacing.
by: Ashrafian, H, et al.
Published: (2007)

Altered Aortic Hemodynamics and Relative Pressure in Patients with Dilated Cardiomyopathy
by: Marlevi, David
Published: (2021)

[Abnormal tropomyosin function in ATPase cycle in hypertrophic and dilated cardiomyopathies].
by: Borovikov, I, et al.
Published: (2013)

Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy
by: Rayner, JJ, et al.
Published: (2020)

MLP and CARP are linked to chronic PKCα signalling in dilated cardiomyopathy
by: Gehmlich, K, et al.
Published: (2016)

Percutaneous mitral valve leaflet repair for mitral regurgitation: Interventional procedures guidance [IPG649]
by: National Institute for Health and Care Excellence, CA, et al.
Published: (2019)

Autosomal dominant familial dilated cardiomyopathy caused by a novel mutation in phospholamban
by: Carballo, S, et al.
Published: (2004)

Cardiomyopathies
by: Chan, K, et al.
Published: (2018)

Functional effects of mutations in troponin T and tropomyosin which cause dilated cardiomyopathy
by: Robinson, P, et al.
Published: (2003)

Mechanical support in dilated cardiomyopathy: signs of early left ventricular recovery.
by: Westaby, S, et al.
Published: (1997)

The role of cardiac energy metabolism and during stress in hypertrophic and dilated cardiomyopathy.
by: Dass, S
Published: (2012)